Related Experiment Video
Updated: Apr 2, 2026
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
Frequent DPH3 promoter mutations in skin cancers
Evgeniya Denisova1, Barbara Heidenreich1, Eduardo Nagore2
1Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany.
Somatic mutations in the DPH3 and OXNAD1 gene promoter regions are frequent in skin cancers, particularly basal cell carcinoma and squamous cell carcinoma. These UV-signature mutations occur near Ets/TCF binding sites, but their functional impact requires further investigation.
Area of Science:
- Genomics
- Cancer Biology
- Dermatology
Background:
- Recent studies indicate cancer-associated somatic mutations frequently occur in genomic regulatory elements.
- Understanding mutations in non-coding regions is crucial for cancer research.
Purpose of the Study:
- To investigate the frequency and characteristics of somatic mutations in the bidirectional promoter of DPH3 and OXNAD1 genes in skin cancers.
- To assess the potential functional impact of these mutations on gene expression.
Main Methods:
- Exome sequencing of 21 melanomas.
- Follow-up screening of 586 skin lesions (melanoma, BCC, SCC, nevi).
- Reporter assays in a melanoma cell line.
Main Results:
- Frequent somatic mutations were identified in the DPH3/OXNAD1 promoter in melanoma, BCC, and SCC, with UV-signature characteristics.
- Mutations were found adjacent to and within an Ets/TCF binding motif.
- Reporter assays showed increased promoter activity with specific mutations, but no observed effect on gene transcription in tumors.
Conclusions:
- The study demonstrates frequent occurrence of non-coding somatic mutations in the DPH3/OXNAD1 promoter in major skin cancers.
- These mutations, exhibiting UV signatures, are located near Ets transcription factor binding sites.
- The functional consequences of these promoter mutations on DPH3 and OXNAD1 transcription in vivo remain to be elucidated.
Related Concept Videos
Abnormal Proliferation
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Induced Pluripotent Stem Cells
Somatic...
The Ras Gene
Ras is a...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Mutations

